These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 602663)

  • 1. The nigrostriatal dopamine system and enhanced reactivity to environmental stimuli: relevance to psychiatric problems [proceedings].
    Antelman SM; Rowland NE
    Act Nerv Super (Praha); 1977 Dec; 19(4):304-6. PubMed ID: 602663
    [No Abstract]   [Full Text] [Related]  

  • 2. [Neurophysiologic and pharmacologic evidence of autoregulationin the nigrostriatal system].
    Arushanian EB; Tolpyshev BA
    Biull Eksp Biol Med; 1981 Feb; 91(2):133-6. PubMed ID: 7194700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Indirect evidence for a feedback loop mechanism between two central dopaminergic pathways: preliminary results.
    Yehuda S
    Commun Psychopharmacol; 1979; 3(2):115-9. PubMed ID: 467002
    [No Abstract]   [Full Text] [Related]  

  • 4. Interactions of D1 and D2 dopamine receptors on the ipsilateral vs. contralateral side in rats with unilateral lesions of the dopaminergic nigrostriatal pathway.
    Sonsalla PK; Manzino L; Heikkila RE
    J Pharmacol Exp Ther; 1988 Oct; 247(1):180-5. PubMed ID: 2971797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is the striato-nigral pathway responsible for 'feed-back' control of dopamine release [proceedings]?
    Arbuthnott GW; Garcia-Munoz M; Nicolaou NM; Tulloch IF; Wright AK
    Br J Pharmacol; 1976 Oct; 58(2):272P. PubMed ID: 974393
    [No Abstract]   [Full Text] [Related]  

  • 6. D1 receptor activation enhances sciatic nerve stimulation-induced inhibition of nigrostriatal dopamine neurons.
    Kelland MD; Freeman AS; Chiodo LA
    Synapse; 1989; 3(4):339-45. PubMed ID: 2525823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nigrostriatal lesion alters neurophysiological responses to selective and nonselective D-1 and D-2 dopamine agonists in rat globus pallidus.
    Carlson JH; Bergstrom DA; Demo SD; Walters JR
    Synapse; 1990; 5(2):83-93. PubMed ID: 2309160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoreceptor-mediated changes in dopaminergic terminal excitability: effects of striatal drug infusions.
    Tepper JM; Nakamura S; Young SJ; Groves PM
    Brain Res; 1984 Sep; 309(2):317-33. PubMed ID: 6089960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Restoration of nigrostriatal synaptic circuitry, striatal mRNA expression, and motor symmetry following embryonic substantia nigra grafts.
    Mendez I; Elisevich K; Naus C; Flumerfelt B
    Clin Neurosurg; 1992; 38():180-209. PubMed ID: 1371434
    [No Abstract]   [Full Text] [Related]  

  • 10. R-(-)-deprenyl (Selegiline, Movergan) facilitates the activity of the nigrostriatal dopaminergic neuron.
    Knoll J
    J Neural Transm Suppl; 1987; 25():45-66. PubMed ID: 2828537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopaminergic receptor activity in substantia nigra in the mechanisms of autoregulation of striatal dopamine release.
    Groppetti A; Parenti M; Cattabeni F; Maggi A; De Angelis L; Monduzzi M; Racagni G
    Adv Biochem Psychopharmacol; 1978; 19():363-71. PubMed ID: 696464
    [No Abstract]   [Full Text] [Related]  

  • 12. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
    Hu XT; White FJ
    Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Behavioural and neurochemical studies on the striatonigral GABA pathway [proceedings].
    Cross AJ; Waddington JL
    Br J Pharmacol; 1979 Jul; 66(3):477P-478P. PubMed ID: 526755
    [No Abstract]   [Full Text] [Related]  

  • 14. [Participation of rat cerebral dopaminergic structures in the process of reproducing conditioned passive avoidance reactions].
    Spiridonov VK
    Neirofiziologiia; 1976; 8(2):209-11. PubMed ID: 1272468
    [No Abstract]   [Full Text] [Related]  

  • 15. [The effect of chronic activation and block of the dopamin- and enkephalinergic systems of the neostriatum on conditioned-reflex behavior abd dopamine metabolism in the nigrostriatal system of rats].
    Iakimovskiĭ AF; Karpova IV
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1992; 42(5):930-5. PubMed ID: 1336279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Control of sensorimotor function by dopaminergic nigrostriatal neurons: influence on eating and drinking.
    White NM
    Neurosci Biobehav Rev; 1986; 10(1):15-36. PubMed ID: 3010199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reciprocal influences of activating and immobilizing stimuli on the activity of nigrostriatal dopamine neurons.
    Chiodo LA; Caggiula AR; Antelman SM; Lineberry CG
    Brain Res; 1979 Nov; 176(2):385-90. PubMed ID: 497813
    [No Abstract]   [Full Text] [Related]  

  • 18. Dopaminergic involvement in the control of drinking behaviour: a brief review.
    Dourish CT
    Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(4-6):487-93. PubMed ID: 6320298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Red light, green light: start/stop signals in nigrostriatal circuits.
    Anderson S
    Neurosurgery; 2011 Feb; 68(2):N15-6. PubMed ID: 21654568
    [No Abstract]   [Full Text] [Related]  

  • 20. Gonadectomy attenuates turning behavior produced by electrical stimulation of the nigrostriatal dopamine system in female but not male rats.
    Robinson TE; Camp DM; Becker JB
    Neurosci Lett; 1981 May; 23(2):203-8. PubMed ID: 7254708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.